This is an academic paper that provides a synopsis of the evidence for buprenorphine in treating opioid use disorder (OUD). The study concludes that buprenorphine is associated with improved outcomes compared with placebo for individuals and pregnant women with OUD and that buprenorphine treatment should be considered for inclusion as a covered benefit.
Thomas, C.P., Fullerton, C.A., Kim, M., et al. (2014). Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatric Services, 65(2), 158-170.